$431 Million is the total value of Altium Capital Management LP's 135 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 78.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOEDWS | New | 1847 GOEDEKER INC*w exp 99/99/999 | $14,737,000 | – | 6,886,600 | +100.0% | 3.42% | – |
| XTNT | New | XTANT MED HLDGS INC | $13,517,000 | – | 8,292,602 | +100.0% | 3.14% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $12,676,000 | +105.3% | 282,445 | +18.5% | 2.94% | +71.5% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $10,048,000 | +81.7% | 533,033 | +47.3% | 2.33% | +51.9% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $9,789,000 | +50.3% | 864,020 | +57.6% | 2.27% | +25.6% |
| CTIC | Buy | CTI BIOPHARMA CORP | $9,197,000 | +436.6% | 3,678,677 | +524.6% | 2.13% | +348.1% |
| KLR | New | KALEYRA INC | $7,834,000 | – | 640,000 | +100.0% | 1.82% | – |
| CHAQ | Buy | CHARDAN HEALTHCR ACQSTN 2 CO | $7,509,000 | -0.8% | 753,874 | +0.1% | 1.74% | -17.1% |
| PALI | New | PALISADE BIO INC | $7,427,000 | – | 1,824,894 | +100.0% | 1.72% | – |
| VSTM | Sell | VERASTEM INC | $6,982,000 | +9.8% | 1,715,589 | -33.3% | 1.62% | -8.2% |
| CRIS | Buy | CURIS INC | $6,690,000 | -23.4% | 829,000 | +7.4% | 1.55% | -36.0% |
| LNTH | Sell | LANTHEUS HLDGS INC | $6,635,000 | +12.9% | 240,066 | -12.7% | 1.54% | -5.7% |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $6,313,000 | +91.5% | 231,314 | +103.0% | 1.46% | +60.0% |
| EPIX | Sell | ESSA PHARMA INC | $6,100,000 | -8.7% | 213,528 | -7.2% | 1.42% | -23.7% |
| ECOR | New | ELECTROCORE INC | $5,950,000 | – | 5,000,000 | +100.0% | 1.38% | – |
| VRCA | Sell | VERRICA PHARMACEUTICALS INC | $5,934,000 | -30.4% | 525,127 | -6.7% | 1.38% | -41.9% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $5,882,000 | +83.9% | 416,567 | +102.4% | 1.36% | +53.6% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $5,869,000 | +519.1% | 1,076,942 | +750.0% | 1.36% | +417.5% |
| CDNA | Sell | CAREDX INC | $5,805,000 | +4.9% | 63,434 | -22.0% | 1.35% | -12.4% |
| INSM | Buy | INSMED INC | $5,787,000 | +54.1% | 203,354 | +84.4% | 1.34% | +28.8% |
| ISEE | IVERIC BIO INC | $5,696,000 | +2.1% | 902,633 | 0.0% | 1.32% | -14.7% | |
| BLU | Buy | BELLUS HEALTH INC NEW | $5,563,000 | -7.9% | 1,788,789 | +13.7% | 1.29% | -23.1% |
| GMED | Buy | GLOBUS MED INCcl a | $5,492,000 | +82.3% | 70,833 | +45.0% | 1.27% | +52.4% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $5,459,000 | +46.2% | 862,417 | +78.5% | 1.27% | +22.2% |
| MYGN | Sell | MYRIAD GENETICS INC | $5,237,000 | +0.1% | 171,242 | -0.3% | 1.22% | -16.3% |
| MEIP | Buy | MEI PHARMA INC | $5,210,000 | +138.0% | 1,828,066 | +186.5% | 1.21% | +98.7% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $5,060,000 | +170.2% | 69,000 | +152.1% | 1.17% | +125.8% |
| MBTC | New | NOCTURNE ACQUISITION CORPordinary shares | $4,930,000 | – | 500,000 | +100.0% | 1.14% | – |
| SIEN | Sell | SIENTRA INC | $4,821,000 | -10.5% | 605,691 | -18.0% | 1.12% | -25.3% |
| CERS | New | CERUS CORP | $4,813,000 | – | 814,328 | +100.0% | 1.12% | – |
| PODD | Sell | INSULET CORP | $4,667,000 | -14.8% | 17,000 | -19.0% | 1.08% | -28.8% |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $4,660,000 | +19.6% | 188,600 | +5.6% | 1.08% | 0.0% |
| NVRO | Sell | NEVRO CORP | $4,460,000 | -15.6% | 26,900 | -29.0% | 1.03% | -29.6% |
| BCTX | New | BRIACELL THERAPEUTICS CORP | $4,266,000 | – | 800,295 | +100.0% | 0.99% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $4,263,000 | -19.7% | 328,908 | -19.6% | 0.99% | -32.9% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $4,243,000 | +100.0% | 609,689 | +127.7% | 0.98% | +67.1% |
| IMTX | IMMATICS N.V | $4,000,000 | +3.6% | 344,558 | 0.0% | 0.93% | -13.4% | |
| INSP | New | INSPIRE MED SYS INC | $3,992,000 | – | 20,655 | +100.0% | 0.93% | – |
| MREO | MEREO BIOPHARMA GROUP PLCads | $3,963,000 | -5.9% | 1,250,000 | 0.0% | 0.92% | -21.4% | |
| EUCR | New | EUCRATES BIOMEDICAL ACQU COR | $3,938,000 | – | 400,000 | +100.0% | 0.91% | – |
| VREX | Buy | VAREX IMAGING CORP | $3,790,000 | +75.0% | 141,319 | +33.7% | 0.88% | +46.3% |
| ILMN | ILLUMINA INC | $3,786,000 | +23.2% | 8,000 | 0.0% | 0.88% | +2.9% | |
| NTRA | New | NATERA INC | $3,773,000 | – | 33,230 | +100.0% | 0.88% | – |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $3,632,000 | -31.6% | 256,152 | -21.5% | 0.84% | -42.9% |
| IMVT | Buy | IMMUNOVANT INC | $3,541,000 | -3.9% | 335,041 | +45.9% | 0.82% | -19.7% |
| IGMS | New | IGM BIOSCIENCES INC | $3,534,000 | – | 42,473 | +100.0% | 0.82% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $3,531,000 | – | 54,500 | +100.0% | 0.82% | – |
| HAE | Buy | HAEMONETICS CORP MASS | $3,532,000 | +86.7% | 53,000 | +211.0% | 0.82% | +56.0% |
| DYN | DYNE THERAPEUTICS INC | $3,506,000 | +35.5% | 166,636 | 0.0% | 0.81% | +13.2% | |
| CELC | New | CELCUITY INC | $3,480,000 | – | 145,000 | +100.0% | 0.81% | – |
| PROF | Buy | PROFOUND MED CORP | $3,440,000 | +35.1% | 210,280 | +66.3% | 0.80% | +12.9% |
| TCRR | TCR2 THERAPEUTICS INC | $3,432,000 | -25.7% | 209,130 | 0.0% | 0.80% | -37.9% | |
| GKOS | Sell | GLAUKOS CORP | $3,427,000 | +0.1% | 40,400 | -1.0% | 0.80% | -16.3% |
| KRMD | New | REPRO MED SYS INC | $3,373,000 | – | 728,487 | +100.0% | 0.78% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $3,337,000 | – | 501,878 | +100.0% | 0.77% | – |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $3,331,000 | +13.3% | 370,551 | +28.1% | 0.77% | -5.3% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $3,194,000 | – | 220,000 | +100.0% | 0.74% | – |
| XENT | Buy | INTERSECT ENT INC | $3,118,000 | +5.3% | 182,456 | +28.6% | 0.72% | -12.0% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $3,114,000 | +235.9% | 93,116 | +106.9% | 0.72% | +180.9% |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,965,000 | -25.6% | 440,589 | 0.0% | 0.69% | -37.8% | |
| STIM | Buy | NEURONETICS INC | $2,957,000 | +73.8% | 184,554 | +34.2% | 0.69% | +45.3% |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $2,883,000 | +7.5% | 775,000 | 0.0% | 0.67% | -10.1% | |
| XENE | New | XENON PHARMACEUTICALS INC | $2,886,000 | – | 155,000 | +100.0% | 0.67% | – |
| AHAC | New | ALPHA HEALTHCARE ACQUISTN COcl a | $2,802,000 | – | 275,000 | +100.0% | 0.65% | – |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $2,794,000 | -11.0% | 934,327 | -3.9% | 0.65% | -25.7% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $2,680,000 | -18.6% | 111,834 | -12.7% | 0.62% | -31.9% |
| HLXA | HELIX ACQUISITION CORP | $2,588,000 | +1.5% | 250,000 | 0.0% | 0.60% | -15.3% | |
| TMPM | New | TURMERIC ACQUISITION CORPcl a | $2,512,000 | – | 254,000 | +100.0% | 0.58% | – |
| LSAQ | LIFESCI ACQUISITION II CORP | $2,500,000 | -1.4% | 250,000 | 0.0% | 0.58% | -17.6% | |
| MCRB | SERES THERAPEUTICS INC | $2,495,000 | +15.8% | 104,626 | 0.0% | 0.58% | -3.2% | |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $2,487,000 | +15.1% | 470,949 | +4.7% | 0.58% | -3.8% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $2,487,000 | -52.7% | 170,484 | -19.0% | 0.58% | -60.5% |
| RGNX | New | REGENXBIO INC | $2,421,000 | – | 62,317 | +100.0% | 0.56% | – |
| SRGA | New | SURGALIGN HOLDINGS INC | $2,417,000 | – | 1,739,131 | +100.0% | 0.56% | – |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $2,345,000 | -3.8% | 225,000 | 0.0% | 0.54% | -19.5% | |
| MORF | Sell | MORPHIC HLDG INC | $2,327,000 | -21.0% | 40,541 | -12.9% | 0.54% | -33.9% |
| FULC | New | FULCRUM THERAPEUTICS INC | $2,238,000 | – | 213,533 | +100.0% | 0.52% | – |
| FATBW | Sell | FAT BRANDS INC*w exp 07/16/202 | $2,229,000 | +111.1% | 233,697 | -22.1% | 0.52% | +76.5% |
| GRTX | New | GALERA THERAPEUTICS INC | $2,162,000 | – | 219,900 | +100.0% | 0.50% | – |
| CARA | New | CARA THERAPEUTICS INC | $2,141,000 | – | 150,000 | +100.0% | 0.50% | – |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $2,053,000 | -56.7% | 104,840 | -53.0% | 0.48% | -63.9% |
| TARS | New | TARSUS PHARMACEUTICALS INC | $2,045,000 | – | 70,573 | +100.0% | 0.47% | – |
| LAAAU | New | LAKESHORE ACQUISITION I CORPunit 06/04/2026 | $2,044,000 | – | 200,000 | +100.0% | 0.47% | – |
| GIWWU | New | GIGINTERNATIONAL1 INCunit 05/19/2026 | $2,008,000 | – | 200,000 | +100.0% | 0.47% | – |
| FSII | FS DEVELOPMENT CORP II | $1,996,000 | +0.2% | 200,000 | 0.0% | 0.46% | -16.3% | |
| JYAC | JIYA ACQUISITION CORP | $1,988,000 | +1.0% | 200,000 | 0.0% | 0.46% | -15.6% | |
| HCAQ | HEALTHCOR CATALIO ACQU CORP | $1,970,000 | -1.5% | 200,000 | 0.0% | 0.46% | -17.7% | |
| EYES | New | SECOND SIGHT MED PRODS INC | $1,847,000 | – | 373,867 | +100.0% | 0.43% | – |
| IMCC | New | IM CANNABIS CORP | $1,709,000 | – | 321,845 | +100.0% | 0.40% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,683,000 | -3.7% | 197,500 | 0.0% | 0.39% | -19.6% | |
| CVRX | New | CVRX INC | $1,680,000 | – | 60,000 | +100.0% | 0.39% | – |
| CYTK | Sell | CYTOKINETICS INC | $1,668,000 | -30.6% | 84,262 | -18.4% | 0.39% | -42.0% |
| KRBP | New | KIROMIC BIOPHARMA INC | $1,604,000 | – | 333,475 | +100.0% | 0.37% | – |
| PCTTW | New | PURECYCLE TECHNOLOGIES INC*w exp 01/28/202 | $1,599,000 | – | 130,875 | +100.0% | 0.37% | – |
| PRTG | New | PORTAGE BIOTECH INC | $1,572,000 | – | 75,000 | +100.0% | 0.36% | – |
| ACET | ADICET BIO INC | $1,464,000 | -21.3% | 142,289 | 0.0% | 0.34% | -34.2% | |
| YMTX | Buy | YUMANITY THERAPEUTICS INC | $1,441,000 | -26.7% | 123,693 | +13.8% | 0.33% | -38.8% |
| VINC | New | VINCERX PHARMA INC | $1,398,000 | – | 107,625 | +100.0% | 0.32% | – |
| ELOX | New | ELOXX PHARMACEUTICALS INC | $1,334,000 | – | 670,118 | +100.0% | 0.31% | – |
| TWND | TAILWIND ACQUISITION CORP | $1,280,000 | +0.5% | 128,414 | 0.0% | 0.30% | -16.1% | |
| AJAX | Buy | AJAX I | $1,245,000 | +21.3% | 125,000 | +25.0% | 0.29% | +1.4% |
| CCAC | Buy | CITIC CAPITAL ACQUISITION CO | $1,102,000 | +10.2% | 111,200 | +11.2% | 0.26% | -7.9% |
| New | ACHIEVE LIFE SCIENCES INC | $1,096,000 | – | 122,000 | +100.0% | 0.25% | – | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $1,072,000 | +2.4% | 100,000 | 0.0% | 0.25% | -14.4% | |
| BLSA | BCLS ACQUISITION CORP | $1,053,000 | -0.4% | 100,000 | 0.0% | 0.24% | -16.7% | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $1,009,000 | – | 15,206 | +100.0% | 0.23% | – |
| MOTV | MOTIVE CAPITAL CORP | $998,000 | -0.3% | 102,099 | 0.0% | 0.23% | -16.9% | |
| QELL | QELL ACQUISITION CORPcl a | $995,000 | -2.3% | 100,000 | 0.0% | 0.23% | -18.4% | |
| OMEG | OMEGA ALPHA SPACcl a | $995,000 | +0.5% | 100,000 | 0.0% | 0.23% | -16.0% | |
| FMAC | FIRSTMARK HORIZON ACQUISITIO | $993,000 | -0.7% | 100,000 | 0.0% | 0.23% | -17.3% | |
| SPNV | SUPERNOVA PARTNERS ACQUISITI | $993,000 | -1.8% | 100,000 | 0.0% | 0.23% | -18.1% | |
| COCP | New | COCRYSTAL PHARMA INC | $970,000 | – | 776,000 | +100.0% | 0.22% | – |
| INMB | New | INMUNE BIO INC | $918,000 | – | 52,257 | +100.0% | 0.21% | – |
| HEPA | New | HEPION PHARMACEUTICALS INC | $883,000 | – | 446,000 | +100.0% | 0.20% | – |
| VLON | Sell | VALLON PHARMACEUTICALS INC | $878,000 | -36.9% | 161,440 | -46.2% | 0.20% | -47.2% |
| MITAU | New | COLISEUM ACQUISITION CORPunit 04/02/2028 | $840,000 | – | 85,000 | +100.0% | 0.20% | – |
| ONCT | Sell | ONCTERNAL THERAPEUTICS INC | $818,000 | -44.2% | 172,218 | -2.3% | 0.19% | -53.3% |
| TKNO | New | ALPHA TEKNOVA INC | $593,000 | – | 25,000 | +100.0% | 0.14% | – |
| CLBRU | New | COLOMBIER ACQUISITION CORPunit 99/99/9999 | $496,000 | – | 50,000 | +100.0% | 0.12% | – |
| ACEV | Sell | ACE CONVERGENCE ACQU CORPcl a | $483,000 | -74.4% | 48,530 | -74.3% | 0.11% | -78.6% |
| IFRX | Sell | INFLARX NV | $479,000 | -84.1% | 161,206 | -79.2% | 0.11% | -86.8% |
| CHAQWS | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $469,000 | -31.8% | 731,561 | 0.0% | 0.11% | -42.9% | |
| AHACW | New | ALPHA HEALTHCARE ACQUISTN CO*w exp 09/21/202 | $385,000 | – | 137,500 | +100.0% | 0.09% | – |
| HCDIW | New | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $378,000 | – | 600,000 | +100.0% | 0.09% | – |
| BCTXW | Sell | BRIACELL THERAPEUTICS CORP*w exp 02/24/202 | $377,000 | -29.5% | 209,540 | -58.1% | 0.09% | -41.6% |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $335,000 | +16.3% | 97,467 | 0.0% | 0.08% | -2.5% | |
| IKT | New | INHIBIKASE THERAPEUTICS INC | $307,000 | – | 109,749 | +100.0% | 0.07% | – |
| RCAT | New | RED CAT HLDGS INC | $266,000 | – | 102,290 | +100.0% | 0.06% | – |
| MBTCR | New | NOCTURNE ACQUISITION CORPright 12/26/2025 | $190,000 | – | 500,000 | +100.0% | 0.04% | – |
| EUCRW | New | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $139,000 | – | 133,333 | +100.0% | 0.03% | – |
| SNCR | New | SYNCHRONOSS TECHNOLOGIES INC | $117,000 | – | 32,500 | +100.0% | 0.03% | – |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $102,000 | -8.9% | 10,000 | 0.0% | 0.02% | -22.6% | |
| BTTR | New | BETTER CHOICE CO INC | $86,000 | – | 20,000 | +100.0% | 0.02% | – |
| TMPMW | New | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $78,000 | – | 84,666 | +100.0% | 0.02% | – |
| UPHWS | New | UPHEALTH INC*w exp 06/08/202 | $9,000 | – | 10,000 | +100.0% | 0.00% | – |
| GLEOWS | Exit | GALILEO ACQUISITION CORP*w exp 10/31/202 | $0 | – | -200,000 | -100.0% | -0.03% | – |
| AMHCW | Exit | AMPLITUDE HLTHCRE AQUSTIN CO*w exp 12/01/202 | $0 | – | -162,500 | -100.0% | -0.04% | – |
| EVAX | Exit | EVAXION BIOTECH A Sads | $0 | – | -24,725 | -100.0% | -0.04% | – |
| GNPX | Exit | GENPREX INC | $0 | – | -60,909 | -100.0% | -0.07% | – |
| CMLFW | Exit | CM LIFE SCIENCES INC*w exp 09/04/202 | $0 | – | -66,666 | -100.0% | -0.10% | – |
| VERB | Exit | VERB TECHNOLOGY CO INC | $0 | – | -281,173 | -100.0% | -0.11% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -89,930 | -100.0% | -0.13% | – |
| VINCW | Exit | VINCERX PHARMA INC*w exp 12/24/202 | $0 | – | -215,250 | -100.0% | -0.24% | – |
| ROCCU | Exit | ROTH CH ACQUISITION II COunit 12/11/2025 | $0 | – | -100,000 | -100.0% | -0.29% | – |
| GIGGU | Exit | GIGCAPITAL4 INCunit 99/99/9999 | $0 | – | -125,000 | -100.0% | -0.34% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -289,114 | -100.0% | -0.35% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -120,000 | -100.0% | -0.37% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -93,261 | -100.0% | -0.38% | – |
| CMLF | Exit | CM LIFE SCIENCES INC | $0 | – | -100,000 | -100.0% | -0.41% | – |
| XGN | Exit | EXAGEN INC | $0 | – | -86,475 | -100.0% | -0.42% | – |
| BWAY | Exit | BRAINSWAY LTDsponsored ads | $0 | – | -179,506 | -100.0% | -0.45% | – |
| SLRX | Exit | SALARIUS PHARMACEUTICALS INC | $0 | – | -1,250,110 | -100.0% | -0.51% | – |
| LCY | Exit | LANDCADIA HOLDINGS III INC | $0 | – | -192,314 | -100.0% | -0.53% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -164,381 | -100.0% | -0.54% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -136,623 | -100.0% | -0.55% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -853,902 | -100.0% | -0.57% | – |
| PXS | Exit | PYXIS TANKERS INC | $0 | – | -2,035,793 | -100.0% | -0.58% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -398,997 | -100.0% | -0.62% | – |
| OCUP | Exit | OCUPHIRE PHARMA INC # | $0 | – | -397,036 | -100.0% | -0.64% | – |
| CHFWU | Exit | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $0 | – | -250,000 | -100.0% | -0.68% | – |
| TMPMU | Exit | TURMERIC ACQUISITION CORPunit 10/08/2025 | $0 | – | -254,000 | -100.0% | -0.70% | – |
| CFMS | Exit | CONFORMIS INC | $0 | – | -2,608,875 | -100.0% | -0.72% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -203,995 | -100.0% | -0.77% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -43,133 | -100.0% | -0.78% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -88,326 | -100.0% | -0.83% | – |
| NBEV | Exit | NEWAGE INC | $0 | – | -1,198,150 | -100.0% | -0.95% | – |
| AHACU | Exit | ALPHA HEALTHCARE ACQUISTN COunit 09/21/2027 | $0 | – | -275,000 | -100.0% | -0.95% | – |
| TFFP | Exit | TFF PHARMACEUTICALS INC | $0 | – | -269,691 | -100.0% | -1.02% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -158,733 | -100.0% | -1.03% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -286,383 | -100.0% | -1.10% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -400,000 | -100.0% | -1.11% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -199,607 | -100.0% | -1.16% | – |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -134,542 | -100.0% | -1.28% | – |
| CLSN | Exit | CELSION CORP | $0 | – | -3,496,154 | -100.0% | -1.34% | – |
| MBTCU | Exit | NOCTURNE ACQUISITION CORPunit 02/25/2026 | $0 | – | -500,000 | -100.0% | -1.39% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -226,719 | -100.0% | -1.43% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -253,448 | -100.0% | -1.57% | – |
| PROG | Exit | PROGENITY INC | $0 | – | -1,748,252 | -100.0% | -2.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.